Clinical trials - Press Releases

Date	Title	Company
10-Dec-2019	Precipice Design Reimagines NIOX VERO® Asthma Detection and Management System	Precipice Design
10-Dec-2019	bluebird bio and Bristol-Myers Squibb Present Updated Data from Ongoing Phase 1 Study of BCMA-Targeted CAR T Cell Therapy bb21217 in Relapsed/Refractory Multiple Myeloma at 61st ASH Annual Meeting and Exposition	Bristol-Myers Squibb
10-Dec-2019	Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen	Genmab A/S
10-Dec-2019	Inceptua Medicines Access and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US	Inceptua
09-Dec-2019	The Alliance for Regenerative Medicine to host European ATMP Access Meeting in Brussels	The Alliance for Regenerative Medicine
09-Dec-2019	Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira®	UCB
09-Dec-2019	ReNeuron Group plc - Interim Results	ReNeuron Group plc
09-Dec-2019	Professor Amit Nathwani will present the Ham-Wasserman Lecture at the 61st ASH Annual Meeting	Freeline
09-Dec-2019	BC Platforms Partners with leading European Genomics Service Provider Life & Brain to Expand Genotyping Services Across Europe	BC Platforms
09-Dec-2019	UKCPA publish recommendations to avoid errors with Syntocinon® & Syntometrine®	UKCPA
09-Dec-2019	Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira®	UCB
09-Dec-2019	ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available	ViiV Healthcare
09-Dec-2019	Takeda and Enzyre to develop diagnostic device allowing hemophilia patients to determine their coagulation status at home	Takeda Pharmaceutical Company Limited
09-Dec-2019	PHARMASEAL Scoops its First Industry Award as Best Start-Up of the Year At Medilink East Midlands Business Awards 2019	PHARMASEAL
09-Dec-2019	PureTech Affiliate Vedanta Biosciences Awarded $5.8 Million CARB-X Grant to Accelerate Development of VE707 for Multi-Drug Resistant Infections	PureTech Health plc
09-Dec-2019	HUMMINGBIRD BIOSCIENCE RAISES US$19 MILLION IN SERIES B FINANCING	Hummingbird Bioscience
09-Dec-2019	PHASTAR Gains 2020 ‘Best Companies’ Accreditation for Employee Engagement	PHASTAR
09-Dec-2019	Orgenesis launches Point of Care cell and gene therapy centers within HYGEIA Group’s Greek hospital network	HYGEIA Group
09-Dec-2019	Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis	Galderma
09-Dec-2019	Gelesis Secures Over $84 Million in New Capital to Support Commercialization of PLENITY™	Gelesis